Is there an association between socioeconomic status, bone mineral density, and vertebral wedge deformities? A team led by researchers at the University of Melbourne in Australia explored this question.
The FDA released a new warning label for the osteoporosis medication Reclast. This article reviews what practitioners should do before prescribing Reclast to osteoporosis patients.
The beneficial effects of teriparatide injections to treat patients with primary osteoporosis may last up to 1 year following the completion of treatment, according to the results of a recent study published online.
Researchers set out to understand the effectiveness of using bone scan imaging to gauge pain in patients with osteoporotic vertebral compression fractures.
Surgical treatment of lumbar/ lumbosacral degenerative disc disease increased by 2.4-fold between 2000 and 2009, according to data from a nationwide, population-based cohort published in the The Spine Journal.
Richard Deyo, MD and Sohail Mirza, MD discuss the current research on lumbar herniated discs, including diagnostic pearls along with the most efficacious treatment options and guidelines.
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Pro ArthMax, a product promoted and sold as a dietary supplement for joint, muscle and arthritic pain.
A common practice for most candidates applying for jobs is to make their resumes more robust possibly by embellishing. What if the candidate never graduated or even attended a school they said they did? How to avoid difficult situations.